Dallas based Etira is aiming to cause apoptosis in cancer cells by targeting LIPA and thus inducing stress in the endoplasmic reticulum

CEO Russell Hayward describes the scientific rationale of this approach, as well as how the company may be weeks away from dosing its first patient in the clinic.

Brought to you by